In concordance with this hypothesis, OA treatment increased MCL-1 phosphorylation at Ser159/Thr163 in MM cell lines with stabilized MCL-1, when the final step of MCL-1 degradation was prevented using a proteasome inhibitor. Here, MCL1 is linked to Miyoshi myopathy.